Introduction: Among the elderly population, chronic osteoarthritis of the knee joint is one of the leading causes of disability and causes considerable pain, joint stiffness, and functional limitations. Although knee replacement is a good option for advanced osteoarthritis, many patients could not undergo surgery due to comorbidities or other reasons. Methods: Four patients with severe pain from grade 3 and 4 osteoarthritis of the knee had undergone ultrasound-guided alcohol neurolysis of the 6 genicular nerves after a positive genicular nerve block with local anesthetics. The demographics, pain intensity (NRS), Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and quality of life (SF-36) were analyzed. Results: There was significant improvement in pain intensity at rest, on movement, and on weight bearing after the neurolysis and it has continued for 6 months (P < 0.05). The OKS and WOMAC score had improved from 7.75 AE 1.25 and 77.75 AE 4.34 at baseline, to 20.75 AE 1.70 and 56.25 AE 3.09 at 1 month, and to 18.25 AE 0.95 and 52.00 AE 2.16 at 6 months after the procedure, respectively (P < 0.05). There was also significant improvement in the quality of life after the procedure (P < 0.05).
INTRODUCTION
Knee osteoarthritis (OA) is one of the leading causes of morbidity among the elderly population and leads to severe pain, stiffness, limitations in movement, sleep and psychological disturbances. [1] [2] [3] [4] To date, many treatment modalities are available depending on the grade of knee OA. Earlier grades of OA are traditionally managed conservatively, whereas surgery (knee arthroplasty) is the option for advanced grades. 5 Most patients with advanced knee OA have multiple comorbidities, making many of them ineligible for surgery. In addition, there are many patients with advanced knee OA who refuse to undergo surgery. Management of these patients puts the physician in a disadvantageous position, as most of the available conservative and less invasive treatment options cannot provide substantial and prolonged relief of symptoms. So, there is always a search for new treatment alternatives that might provide a new horizon for patients with severe OA who also have comorbidities. There has recently been considerable interest in the role of radiofrequency ablation (RFA) of the genicular nerves for knee OA. In the majority of previous studies, ablation was done via a radiofrequency technique using either fluoroscopy or ultrasound for only three genicular nerves, whereas the knee joint is also supplied by a few other nerves. [6] [7] [8] [9] [10] [11] Interestingly, neurolytic agents can also be used to ablate the nerves, and are readily available, less costly, and need less logistic support. There is a recent update in literature about the blockade of seven genicular nerves supplying the knee using ultrasound. 12 We tried ultrasound-guided neurolysis of six genicular nerves in four patients with advanced knee OA who had severe knee pain, with previous failed conservative treatment and genicular RFA.
METHOD
We performed a retrospective analysis of 4 patients who had undergone ultrasound-guided alcohol neurolysis of genicular nerves of the knee for severe pain (Kellgren and Lawrence grade 3 or 4 OA) over a period of 10 months from September 2014 to June 2015 in the Asian Institute of Medical Sciences, Faridabad, India. The previous conservative and minimally invasive treatments had been unsuccessful in all the patients, and they were not willing to undergo surgery due to multiple comorbidities. The patients had undergone RFA of their genicular nerves under fluoroscopic guidance for only 3 of the genicular nerves with no relief in the last attempt. They had also been offered ultrasound-guided RFA of the genicular nerves, which they had refused and instead opted for ultrasound-guided neurolysis, which was a novel technique. The potential benefits and unwanted risks pertaining to this novel procedure were explained in detail to all patients, and written informed consent for the procedure and for the subsequent publication of the results was obtained. The patients also consented to regular follow-up at specific intervals for 6 months and were required to supply responses to the Oxford Knee Score, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the 36-Item Short Form Health Survey (SF-36) at each visit.
Diagnostic Genicular Nerve Block
Both the diagnostic genicular nerve block and therapeutic neurolysis were performed in an operating theater under aseptic and antiseptic conditions. The patients were positioned supine; and monitors (electrocardiograph, pulse oximeter, and noninvasive blood pressure device) as per ASA standards were attached, and an intravenous access was secured. 
SMGN:
The SMGN arises from the nerve to the vastus medialis, which itself is a branch of the femoral nerve and gives sensory innervation to the medial retinaculum and medial joint capsule. The ipsilateral hip was externally rotated to place the medial aspect of the knee facing superiorly. The transducer was placed transversely over the medial femoral epicondyle and then moved proximally to the level of the adductor tubercle and insertion of the adductor magnus tendon. The SMGN and vessels were found to be lying together just proximal and anterior to the adductor tubercle, and the needle was directed in an in-plane approach ( Figure 1 ). 2. SLGN: The SLGN arises from the nerve to the vastus lateralis, which is a branch of the femoral nerve and innervates the superolateral aspect of the joint capsule. The ipsilateral hip was internally rotated to position the lateral aspect of the knee facing superomedially. The USG probe was placed transversely over the lateral aspect of the femur at the junction of the lateral epicondyle and shaft of the femur. The SLGN and vessels were better visualized more proximally near the myotendinous junction of the vastus lateralis, and the needle was directed from an anterior to posterior direction in an in-plane approach (Figure 2 ). 3. MGN: The MGN, also known as the medial retinacular nerve, is a terminal branch of the femoral nerve supplying the superior and anterior aspects of the knee capsule. The knee was flexed with a pillow under it, and the USG probe was oriented transversely over the lower end of the anterior aspect of the femur just at the upper part of the suprapatellar bursae. The needle was directed in an in-plane approach in a lateral to medial direction towards the MGN, which lies between the fascia of the rectus femoris, vastus intermedius, vastus medialis, vastus lateralis, and suprapatellar bursae ( Figure 3 ). 4. RPN: The RPN arises from the common perineal nerve and provides sensory innervation to the inferolateral and anterior aspects of the knee joint. The knee was flexed and the hip internally rotated to position the lateral aspect of the knee joint facing superolaterally. The USG probe was oriented transversely over the anterolateral aspect of the tibial condyle. The needle was inserted in an in-plane approach from the lateral to medial side of the knee towards the RPN, which lies in close proximity to the anterior tibial recurrent artery, which lies anterior to the neck of the fibula and anterolateral tibial condyle, just lateral to Gerdy's tubercle ( Figure 4 ). 5. IMGN: The IMGN arises from the infrapatellar branch of the saphenous nerve and supplies the pes anserine tendon insertion area, medial collateral ligament, and medial, anterior, and inferior joint capsules. The knee was flexed and the hip externally rotated to position the medial aspect of the knee joint facing superomedially. The USG probe was then oriented along the short axis of the tibia and medial collateral ligament. The needle was inserted in an in-plane approach from medial to lateral direction towards the IMGN, which lies in near proximity to the inferior medial genicular artery and just below the medial collateral ligament at the junction of the medial condyle of the tibia and its shaft ( Figure 5 ).
ILGN:
The ILGN is a branch of the common peroneal nerve and provides sensory innervation to the lateral aspect of the knee joint. The knee was flexed and the hip internally rotated to position the lateral knee joint facing superolaterally. The USG probe was oriented along the short axis of the tibia at the lateral border of the tibial condyle. The ILGN lies at the lateral knee joint line, underneath the lateral collateral ligament, or at the lateral tibial condyle near the attachment of the lateral coronary ligament along with the lateral inferior genicular artery, and the needle was inserted in an in-plane approach towards it ( Figure 6 ).
Under ultrasound guidance, a 22-gauge 50-mm SonoPlex Stim cannula (Pajunk Medical Systems L.P., Norcross, GA, U.S.A.) was advanced towards the nerve. A nerve stimulator (NS-100; Inmed Equipments Private Limited, Vadodara, India) was also used to elicit paresthesia along the area of the knee joint supplied by that particular genicular nerve by stimulating at 50 Hz with a current of < 0.5 mV. A volume of 1.5 to 2 mL of 2% lignocaine was injected around the nerve, and it was seen encircling it under ultrasound. If the block resulted in more than 50% reduction in pain intensity for more than 2 hours at rest, on movement, and on walking for 5 minutes, it was considered successful. The patients had been given the option of therapeutic neurolysis if they had 2 successive positive diagnostic genicular nerve blocks, given at an interval of 3 weeks.
Therapeutic Genicular Nerve Block or Neurolysis
Therapeutic neurolysis was performed in the same way as the diagnostic genicular nerve block. However, for neurolysis, instead of 2 mL of 2% lignocaine, we used 0.5 to 0.75 mL of a solution containing 50% alcohol in 0.25% bupivacaine. An additional 0.5 or 0.75 mL of 2% lignocaine was required in some instances, as a few patients complained of immediate severe pain during alcohol injection. After the procedure, the patients were observed for a minimum of 3 hours for immediate pain relief and any immediate complications. All the patients were discharged within the same day after the procedure.
Assessments
Follow-up of patients was done for 6 months, with assessments before the procedure and at 1 and 6 months after neurolysis. Pain intensity was measured on the numeric rating scale (NRS) at rest, on movement, and on walking for 5 minutes. Physical pain, stiffness, and function were measured using the Oxford Knee Score and WOMAC index. Quality of life was measured using the SF-36 (36-Item Short Form Health Survey). The NRS is an 11-point scale depicting pain on a linear scale of 0 (no pain) to 10 (worst pain imaginable). The Oxford Knee Score is a 12-point self-administered questionnaire, with each item scored from 0 (worst symptom/outcome) to 4 (no symptoms/best outcome). The WOMAC is a 24-point scale having 5 items for pain, 2 items for stiffness, and 17 items for physical functions. SF-36 is a 8 domain scale to measure the change in perceived health and has 8 domains to measure health that includes physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. 
RESULTS

Demographic Features
The average age of patients was 64.5 AE 5.19 years. There were three male patients and one female patient. Interestingly, all the patients were obese, with an average body mass index of 31.83 AE 2.0. The patients had experienced knee pain for a long time (average of 51.0 AE 7.74 months). Two patients had Kellgren and Lawrence grade 3 and the other two had grade 4 OA. Three patients had pain in the right knee, while 1 had pain in the left knee (see Table 1 ).
Medications
Patients were taking paracetamol and antineuropathic medications regularly, with relief in pain of 10% to 15% lasting for only a few hours, and requiring nonsteroidal anti-inflammatory drugs occasionally, giving relief of up to additional 20% (see Table 1 ).
Previous Treatments
All patients had previously undergone conservative treatment with physiotherapy and other options (e.g, knee braces, modified shoes, etc.), with minimal relief. They had also undergone minimally invasive procedures like intra-articular injections of steroid, hyaluronic acid, platelet-rich plasma, and genicular nerve RFA. Genicular nerve radio-frequency ablation had been performed earlier for only 3 nerves under fluoroscopic guidance.
Pain Intensity
Neurolysis resulted in significant improvement in pain intensity (NRS) at all the three occasions of rest, on movement and on walking, which persisted for 6 months (P < 0.05) (Figures 7-9 ). All patients experienced more than 50% relief in pain intensity at rest after 1 month, while on movement and on walking 50% of patients had more than 50% relief. At 6 months, 50% of patients had 50% relief in pain intensity at rest and on movement, whereas on walking for 5 minutes the patients had more than 30% relief.
Physical Function and Stiffness
The OKS improved significantly from 7.75 AE 1.25 at baseline to 20.75 AE 1.70 and 18.25 AE 0.95 at 1 and 6 months, respectively (P < 0.05) (Figure 10 ). The WOMAC score also improved significantly from 77.75 AE 4.34 at baseline to 56.25 AE 3.09 and 52.00 AE 2.16 at 1 and 6 months, respectively, after the procedure (P < 0.05) (Figure 11 ).
Quality of Life
Quality of life had also improved after the neurolysis. The physical health domain of quality of life improved significantly from 27.22 AE 6.95 at baseline to 47.12 AE 2.63 and 51.27 at 1 and 6 months, respectively, after neurolysis (P < 0.05) (Figure 12 ). The mental health domain also improved, from 35.35 AE 3.30 at baseline to 52.45 AE 1.82 and 54.02 AE 2.59 at 1 and 6 months, respectively (P < 0.05) (Figure 13 ).
Complications and Adverse Events
No major immediate or delayed complications were observed in any of the patients. However, 1 patient developed hypoesthesia and another had numbness, both of which did not cause much discomfort to the patients and had resolved within 6 months. Interestingly, no patient complained of an increase in pain, hyperalgesia, or anesthesia dolorosa after the procedure.
DISCUSSION
This is the first reported case series in literature describing the genicular nerve neurolysis for severe pain from knee OA using a neurolytic agent alcohol.
In our patients, neurolysis resulted in significant improvement in pain intensity at rest, on movement, and on walking, and it persisted for 6 months. There was also significant improvement in physical function and stiffness after the procedure, and the improvement persisted beyond 6 months. Furthermore, these led to improvement in quality of life persisting for more than 6 months.
In the majority of previous studies, RFA was performed for only 3 genicular nerves, the SMGN, SLGN, and IMGN. [6] [7] [8] [9] [10] [11] Interestingly, the knee joint is supplied by a few other branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves.
2 So, it is apparent that the previous studies using radiofrequency of 3 genicular nerves might have failed to block the lion's share of nerves supplying the joint. [6] [7] [8] [9] [10] [11] There are a few recent studies in which the nerves supplying the knee were described very well with their anatomical locations. [13] [14] [15] Recently, Lam described the technique to block 7 genicular nerves supplying the knee joint. 12 Using this technique, we additionally blocked the MGN, RPN, and ILGN. We avoided blocking the posterior genicular nerve plexus due to its proximity to the tibial nerve. In previous studies, many patients failed to get relief in pain because the knee joint's nerve supply was not blocked totally, as compared to our study, in which we blocked 3 additional genicular nerves. We believe this is the reason for the good and long-lasting pain relief in severe advanced OA seen in our patients.
In most of the earlier studies, the fluoroscopy technique was used, which relies on the perceived anatomical location of the genicular nerves in relation to bone, and it may not be accurate in all instances since there may be variations in the relationship between the bone and the genicular nerve branches. [6] [7] [8] However, in many recent studies, ultrasound was used, and it was observed that nerves can be better visualized using ultrasound and that there is less likelihood of injuring the nerve, which may occur with fluoroscopy. [9] [10] [11] Furthermore, the genicular vessels are in close proximity to the genicular nerves and run the risk for being injured during the procedure. 16 The risk for injuring these vessels is higher with the fluoroscopic technique as compared to the ultrasound technique; interestingly, the safety profile increases further with the additional use of the Doppler technique to visualize the vessels with ultrasound guidance.
The genicular nerves are sensory branches supplying the knee joint only, so there is no room for motor damage. Furthermore, the spillage of the neurolytic agent to the surrounding structures is avoided by the use of ultrasound via which the nerve, needle, and also the injection of the neurolytic agent can be seen in real time. Because the injection was seen in real time using ultrasound, the spread of the neurolytic agent could be controlled. Although 1 patient experienced numbness and another complained of hypoesthesia, it did not cause much discomfort and had resolved within 6 months. Damage to the articular and other nonarticular structures around the knee joint was avoided by the use of ultrasound, which enabled us to visualize the nerve more accurately and helped us to determine the direction of the needle. These structures were avoided because all the injections were done in an inplane approach, and real-time visualization of the injection helped us to avoid spilling the neurolytic agent into nearby structures.
Although a few complications of the ablation of peripheral nerves with neurolytic agents (eg, reactive neuritis, neuroma formation, deafferentation pain, anesthesia dolorosa) have been described in the literature, none of these types of complications were observed in our study. 17, 18 Franco et al. found that there is great variability in the position of the genicular nerves in relationship to bones, and that normal conventional RFA under fluoroscopic guidance may not be effective; 5 to 7 conventional transverse radiofrequency lesions may be required to cover all the nerves. 16 They found that even bipolar RFA required 2 contiguous radiofrequency lesions to cover the anatomical variation as compared to a single lesion from cool RFA. However, both cool and bipolar RFA produces bigger leisons , but are very costly and requires more advanced machine than conventional RFA. Also, with the traditional technique conventional RFA is unreliable in ablating the nerves. To the contrary, with the use of ultrasound guidance, the 6 nerves can be visualized and ablated in a more effective way. In our study, we used another novel agent alcohol, which is readily available and produces the same results as RFA.
Chemical neurolysis of the genicular nerves does not require an expensive equipment like RFA and can be useful in settings with limited resources since it requires only a sterile environment and a good ultrasound machine.
The limitations of our study are that it is a retrospective case series with a small number of patients with limited follow-up.
CONCLUSION
Ultrasound-guided alcohol neurolysis is a safe and effective alternative technique for patients with severe pain from knee OA who are either not willing to undergo surgery or not amenable to it due to comorbidities, and it provides significant and prolonged pain relief for more than 6 months. More randomized, double-blinded, sham-controlled studies with larger sample sizes and prolonged follow-up are required.
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